Painful watching a great drug limp along not directly helping mankind. Maybe it isn't such a great drug. I guess the last trial was the one to nail it and unfortunately we missed the mark(fall of 2019). The deck seems stacked against us except for our Break Through Designation and some hope as a therapeutic for Covid.  Does Covid prevent us from doing a proper trial on the main event, I guess? Lack of funds is definitely an issue. At least what we know of.   When they run out of these exempt dribbles maybe the only choice will be to seek govt. assistance at this rate. In the meantime, we dribble on a shame really. Maybe Don can run a Covid Trial by the skin of his teeth and surprise us all and keep dilution down and generate revenue. At least we have our peer-reviewed papers up to date.